Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sucrosofate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPSE | Q9Y251 | 16/20 | 0.55 |
| ▸ | FGF1 | P05230 | 9/20 | 0.48 |
| ▸ | FGF2 | P09038 | 6/20 | 0.48 |
| ▸ | VEGFA | P15692 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sucrosofate SCHEMBL28961186 | 1.00 | HPSE (0.55) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL8699894 | 0.99 | HPSE (0.54) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL15485823 | 0.98 | HPSE (0.52) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL3086839 | 0.98 | HPSE (0.52) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL15653532 | 0.98 | HPSE (0.52) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL18467935 | 0.79 | FGF1 (0.74) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL16661862 | 0.79 | FGF1 (0.74) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL145069 | 0.79 | FGF1 (0.74) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL16661861 | 0.79 | FGF1 (0.74) | HPSEFGF1FGF2VEGFA | |
| Sucrosofate SCHEMBL145070 | 0.79 | FGF1 (0.74) | HPSEFGF1FGF2VEGFA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119139530-B | Dressing for diabetic foot wound surface and preparation method thereof | 南方医科大学南方医院 | 2025-01-14 | — | — | CN | claimed |
| CN-119220132-A | Preparation process of quick-drying perchloroethylene paint layer | 上海夏宁新材料科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119139530-A | Dressing for diabetic foot wound surface and preparation method thereof | 南方医科大学南方医院 | 2024-12-17 | — | — | CN | claimed |
| CN-117618531-B | Antibacterial pharmaceutical composition, colloidal particles surrounded by interfacial film, preparation method and application thereof | 晟迪生物医药(苏州)有限公司 | 2024-12-06 | — | — | CN | claimed |
| WO-2024199424-A1 | PHOSPHOLIPID COMPOSITION, PREPARATION METHOD THEREFOR AND USE OF NITROGEN-CONTAINING COMPOUND | 上海济煜医药科技有限公司 | 2024-10-03 | — | — | WO | claimed |
| CN-108993456-B | Rabies virus adsorption chromatography medium and preparation method thereof | 武汉汇研生物科技股份有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-112239953-A | Non-woven fabric surface treatment finishing agent composition and preparation method and application thereof | 江苏盛纳凯尔医用科技有限公司 | 2021-01-19 | — | — | CN | claimed |
| CN-110878177-A | Special pigment carbon black dye and preparation method thereof | 庄明磊 | 2020-03-13 | — | — | CN | claimed |
| EP-2861301-B1 | COMPOSITION, IN AN AQUEOUS MEDIUM, INCLUDING AT LEAST ONE HYALURONIC ACID AND AT LEAST ONE SUCROSE OCTASULPHATE WATER-SOLUBLE SALT | LAB VIVACY (FR) | 2019-02-20 | — | — | EP | claimed |
| CN-108993456-A | A kind of rabies viruses adsorption chromatography medium and preparation method thereof | 武汉汇研生物科技股份有限公司 | 2018-12-14 | — | — | CN | claimed |
| CN-108503974-A | Cold-resistant PVC sheet | 台州久通塑胶有限公司 | 2018-09-07 | — | — | CN | claimed |
| CN-107693616-A | A kind of composition of preventing diaper dermatitis and its preparation method and application | 泉州市晋江恒安卫生科技有限公司 | 2018-02-16 | — | — | CN | claimed |
| CN-102014979-B | Comprise for active component or the implantable medical device of the protective layer/retention layer of medicine, particularly water-soluble active ingredient or medicine | HEXACATH (FR) | 2016-11-30 | — | — | CN | claimed |
| CN-103720642-A | Bioprotein-containing solution for external use and preparation method thereof | BEIJING TIDE PHARMACEUTICAL CO LTD | 2014-04-16 | — | — | CN | claimed |
| CN-102014979-A | Implantable medical device including a protection/retaining layer for an active ingredient or drug, in particular a water-soluble one | HEXACATH | 2011-04-13 | — | — | CN | claimed |
| EP-0691976-A1 | ANTICOAGULANT COMPOUNDS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1996-01-17 | — | — | EP | claimed |
| WO-1994022885-A1 | ANTICOAGULANT COMPOUNDS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1994-10-13 | — | — | WO | claimed |
| CN-121951939-A | Uniform dyeing and high-fixation piece dyeing process suitable for various fabrics | 广东启悦未来科技有限公司 | 2026-05-01 | — | — | CN | disclosed |
| US-4990610-A | Reacting Sucrose with Chlorosulfonic acid and 2-Picoline | APPLIED ANALYTICAL INDUSTRIES, INC. (US) | 1991-02-05 | — | — | US | disclosed |
| WO-1990002133-A1 | METHOD FOR PREPARING SUCRALFATE AND AAI-10001 | FORMULATIONS DEVELOPMENT LABORATORIES, INC. (US) | 1990-03-08 | — | — | WO | disclosed |